🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 16 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/03/1999 | 34,15 | 35,56 | 32,75 | 33,45 | -2,05% | 8,22% | 64.654 |
| 05/03/1999 | 36,03 | 36,96 | 33,69 | 34,15 | -3,95% | 9,09% | 104.275 |
| 04/03/1999 | 33,69 | 35,56 | 33,69 | 35,56 | +5,56% | 5,56% | 43.976 |
| 03/03/1999 | 36,03 | 36,26 | 33,69 | 33,69 | -5,26% | 7,14% | 46.594 |
| 02/03/1999 | 36,96 | 36,96 | 35,56 | 35,56 | -1,30% | 3,80% | 47.769 |
| 01/03/1999 | 36,73 | 37,90 | 35,09 | 36,03 | -1,91% | 7,64% | 110.473 |
| 26/02/1999 | 36,49 | 37,66 | 35,79 | 36,73 | +0,00% | 5,13% | 169.838 |
| 25/02/1999 | 35,56 | 36,96 | 35,09 | 36,73 | +3,29% | 5,26% | 78.894 |
| 24/02/1999 | 38,37 | 38,37 | 35,56 | 35,56 | -7,32% | 7,32% | 92.199 |
| 23/02/1999 | 37,66 | 38,83 | 36,96 | 38,37 | +2,50% | 4,97% | 64.868 |
| 22/02/1999 | 39,30 | 39,54 | 36,96 | 37,43 | -6,98% | 6,55% | 156.934 |
| 19/02/1999 | 39,07 | 41,17 | 38,83 | 40,24 | +4,24% | 5,99% | 181.647 |
| 18/02/1999 | 45,15 | 45,38 | 37,43 | 38,60 | -16,67% | 17,62% | 280.578 |
| 17/02/1999 | 48,19 | 48,42 | 46,32 | 46,32 | -4,35% | 4,37% | 68.956 |
| 16/02/1999 | 47,72 | 48,66 | 47,49 | 48,42 | +1,47% | 2,45% | 64.173 |
| 12/02/1999 | 48,66 | 48,66 | 47,72 | 47,72 | -3,77% | 1,92% | 76.383 |
| 11/02/1999 | 50,06 | 50,06 | 49,13 | 49,59 | -0,93% | 1,87% | 125.301 |
| 10/02/1999 | 50,06 | 50,53 | 49,13 | 50,06 | -1,38% | 2,80% | 84.184 |
| 09/02/1999 | 52,40 | 52,64 | 48,66 | 50,76 | -2,69% | 7,59% | 223.378 |
| 08/02/1999 | 52,64 | 55,21 | 51,47 | 52,17 | +13,78% | 7,11% | 782.665 |
| 05/02/1999 | 47,26 | 48,66 | 45,85 | 45,85 | +0,00% | 5,94% | 144.270 |
| 04/02/1999 | 44,68 | 47,26 | 43,04 | 45,85 | +4,26% | 9,42% | 142.346 |
| 03/02/1999 | 47,26 | 47,72 | 43,98 | 43,98 | -3,09% | 7,92% | 115.443 |
| 02/02/1999 | 45,38 | 46,79 | 45,38 | 45,38 | -2,02% | 3,09% | 46.033 |
| 01/02/1999 | 48,42 | 48,66 | 45,38 | 46,32 | -3,88% | 6,76% | 118.862 |
| 29/01/1999 | 48,66 | 48,89 | 46,79 | 48,19 | -0,96% | 4,33% | 97.356 |
| 28/01/1999 | 48,89 | 49,83 | 46,79 | 48,66 | +1,96% | 6,22% | 251.270 |
| 27/01/1999 | 45,62 | 48,66 | 45,38 | 47,72 | +5,15% | 7,18% | 137.163 |
| 26/01/1999 | 43,04 | 45,38 | 42,58 | 45,38 | +7,18% | 6,52% | 109.806 |
| 25/01/1999 | 42,34 | 43,04 | 41,41 | 42,34 | +2,26% | 3,87% | 96.634 |